Corporate Development, Business Development, In-Licensing, Out-Licensing, Collaborations, Strategic Transactions, High-Value Customer and Vendor Relationships, Commercial Pipeline StrategyBusiness Transaction and Legal Leadership in BD, Commercial, Strategic Alliances, Commercial, ContractingExecutive-Level Restructuring Committee

Involved in Corporate Development, Business Development, Licensing, Collaboration, Strategic Transactions, Academic Medical University Collaboarations, Financial and Legal Oversight, and general Board Advising

Virtual Pharma: Bessor employs a "virtual pharma" development model where it outsources all drug development activities supervised by its small core team of drug development experts. (www.bessorpharma.com) Translating research from leading academic medical centers into clinical-stage pharma/biotech programs. Currently 3 drug development programs: (1) Renalase Agonists for Acute Kidney Injury (AKI), Acute Pancreatitis (AP), and COVID-19(2) Anti-Renalase Anti-body (mAb) for Melanoma, Pancreatic Cancer, and other hard to treat solid tumors(3) Synthetic Chemistry Platform to design hard to produce natural productsAllan's responsibilities include: - Lead legal and licensing activities.- Manage intellectual property (IP) portfolio and plans, supervising internal IP professional and outside IP counsel. - Draft and negotiate agreements with external service providers for all development functional areas including: preclinical, clinical, manufacturing, regulatory, quality assurance, and commercial.- Advise executive management on contractual obligations and compliance issues.- Manage budgeting and financial matters, including directing outside accounting firm

Engaged via Axiom by American Regent/Luitpold Pharmaceuticals (subsidiary of Daiichi Sankyo) to serve as the lead business lawyer for acquisition, divestiture, in-licensing, out-licensing, strategic alliance, collaboration, co-promotion , m&a, product development, and joint venture transactions. Advised Commercial team and Chief Commercial Officer about pricing matters and customer (GPOs, IDNs, wholesaler, etc.) contracting. Prepared antitrust and competition policy.

Engaged via Axiom by Millennium Pharmaceuticals/Takeda Pharmaceuticals in Cambridge, MA to serve as a lead business lawyer for early and late stage product development transactions including in-licensing, strategic alliances, collaborations, co-promotion agreements, mergers, and acquisitions.

Drafting and reviewing Private Placement Memoranda and Offering Documents for start-up companies in fundraising rounds.Advised a health technologies company on expanding service offerings into the clinical trials market.Sophisticated Corporate Attorney with Expertise in:Private Equity/Venture Capital Investment, Due DiligenceBio-Tech/Pharma Transactions - Licensing, Collaborations, Joint Ventures, M&A, Financing, StructuringStart-up Structuring, Financing Commercial/Industrial Real Estate Finance and LeasingTechnology Transactions and Commercial ContractsBio-Tech/Pharma/Life Sciences Commercial ContractsM&AAdvising Boards of Directors

Initial Head of Legal for Auven Therapeutics/Celtic Therapeutics' portfolio company ADC Therapeutics. Structured (with Swiss and tax counsel) initial formation of ADC Therapeutics to license PBDs and antibody linker technology from Auven Therapeutics/Celtic Therapeutics' portfolio company Spirogen. Advised on firewall between Spirogen and ADC Therapeutics to separate Spirogen's licensing business model from ADCT's drug development business model. Prepared and negotiated collaboration deals with antibody companies to set out future commercial relationships with antibody companies. Organized and ran board meetings.

Reported to CEO of biotech venture capital firm Auven Therapeutics (formerly known as Celtic Therapeutics) and related predecessor biotech venture capital fund Celtic Pharma Development. Oversaw the day-to-day legal and transaction operations, including transaction structuring/negotiation, licensing, collaborations, joint ventures, M&A, corporate formation, fund formation, employment matters, and due diligence. Head of Legal for product portfolio companies, including Spirogen (acquired by AstraZeneca’s MedImmune) and ADC Therapeutics (www.adctherapeutics.com). Set up framework for collaborations and development relationships between ADC Therapeutics and antibody companies. Primary counsel for initial transactions surrounding now marketed product CEQUA™ (cyclosporine ophthalmic solution) 0.09% is a calcineurin inhibitor immunosuppressant indicated to increase tear production in patients with keratoconjunctivitis sicca (dry eye). https://cequapro.com/http://www.auventx.com/Celtic Therapeutics seeks to partner with biotechnology and pharmaceutical companies, contract research organizations (CROs), academic institutions and other appropriate healthcare organizations to bring valuable life-saving and quality of life-enhancing biomedical products to the global marketplace.Celtic Pharmaceutical Holdings L.P. (Celtic Pharma) is a $400 million global private equity investment firm focused on the biotechnology and pharmaceutical industries. Based in Bermuda, with offices in New York and London, Celtic Pharma acquires and invests in late stage pharmaceutical programs and manages these programs through to regulatory approval.

On-site Counsel to:Goldman Sachs - Technology TransactionsAmerican Express - New Licensed Card Business Framework (MBNA)Schrodinger (DE Shaw-backed company) - Interim General CounselCeltic Pharma - Head of LegalProvided out-sourced, on-site general counsel services to clients. Areas of expertise: Venture Capital and Private Equity Transactions, M&A, Financing, Commercial Contracts. Primary Industry Focus: Technology and Bio-technology. Financial Services.Past clients: Goldman Sachs, Schrodinger (D.E. Shaw), American Express, Ameriprise, Five Points Partners, eChalk, Celtic Pharma. www.axiomlegal.com

- Drafted and negotiated technology commercial transactions, including: license agreements for third party content, software, data, telecommunications, and outsourcing agreements.- Legal project manager on major technology acquisitions, collaborating with business and technology groups.

Corporate, Securities, Restructuring, Bankruptcy, M&A, Financing

Public Company General CounselFiled initial registration statement with SECStructured and Negotiated acquisitions, joint ventures, strategic alliancesTechnology IncubatorSeeded and led B2B Internet Market-Maker CompaniesBoard designee to portfolio company that was NYSE-listedHandled 40-Act issues surrounding transient investment company rules

Corporate, Securities, Restructuring, Project Finance, M&A, Financing

Audit and Business Advisory ServicesClients included: Manor Care, Inc., Choice Hotels International, Childrens National Medical Center, Charles E. Smith Real Estate, Carlyle Group, U.S. National Holocaust Museum, National Council of LaRaza, NatPac

LBJ Congressional Intern program - worked in both Washington DC Office and District Office in Norristown, PA